UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029724
Receipt number R000033965
Scientific Title Prospective study on adaptive radiotherapy using treatment room CT
Date of disclosure of the study information 2018/01/01
Last modified on 2022/04/30 14:35:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective study on adaptive radiotherapy using treatment room CT

Acronym

Prospective study on adaptive radiotherapy using treatment room CT

Scientific Title

Prospective study on adaptive radiotherapy using treatment room CT

Scientific Title:Acronym

Prospective study on adaptive radiotherapy using treatment room CT

Region

Japan


Condition

Condition

Pharyngeal & Laryngeal cancer

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

In this clinical trial, the treatment room CT of radiotherapy patients is deformed on Eclipse, the volumetric change and the position change amount of the target and the risk organs are measured, the dose change is confirmed, and the optimal timing of the re-treatment plan is measured It is aimed at.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Timing at which dose change occurs in treatment room CT (week number)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

We will shoot by expanding the shooting range in the treatment room CT not to the conventional 16 cm, but to 32 cm including the entire irradiation range.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients with pharyngeal / laryngeal cancer with diagnosis of malignant tumor by histopathological examination
2) Patients who undergo radical chemoradiotherapy or radiotherapy alone (60-70 Gy / 30-35 fractions) to the macroscopic tumor volume of the primary tumor
3) Performance status (ECOG): 0 to 2
4) Patients whose age at registration is 20 years or over, 80 years old or younger
5) About participation in the study Informed consent is obtained from the patient himself.

Key exclusion criteria

1) Patients with radiation therapy alone
2) Patients judged inappropriate by the attending physician
3) Patients who took only less than five shots from the treatment cen- tory CT in the treatment room.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yasumasa
Middle name
Last name Nishimura

Organization

Kindai University Faculty of Medicine

Division name

Department of Radiation Oncology

Zip code

589-8511

Address

377-2, Ohno-Higashi, Osaka-Sayama, Osaka

TEL

072-366-0221

Email

ynishi@med.kindai.ac.jp


Public contact

Name of contact person

1st name Kazuki
Middle name
Last name Ishikawa

Organization

Kinndai University Faculty of Medicine

Division name

Department of Radiation Oncology

Zip code

589-8511

Address

377-2, Ohno-Higashi, Osaka-Sayama, Osaka

TEL

072-366-0221

Homepage URL


Email

k-ishi@med.kindai.ac.jp


Sponsor or person

Institute

Kindai University

Institute

Department

Personal name



Funding Source

Organization

Ministry of education

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kindai University Faculty of Medicine Ethics Committee

Address

377-2, Osaka-sayama, Osaka, Japan

Tel

072-366-0221 (ext. 3756)

Email

zizen@med.kinda.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 01 Day


Related information

URL releasing protocol

Unpublished

Publication of results

Unpublished


Result

URL related to results and publications

Unpublished

Number of participants that the trial has enrolled

30

Results

Although volume and dose changes in IMRT for head and neck cancers tend to be consistent, they vary from case to case and require an individualized retreatment plan.

Results date posted

2020 Year 10 Month 29 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Gender: 21 males, 5 females.
Age 40-75 (64 in the center)
Total line 66-70Gy Central value 70Gy (66Gy for NEC, 70Gy for other 29 cases).

PS0 :1 :2 = 23 :2 :1

Participant flow

Consent was obtained from 30 patients with head and neck cancer treated with chemoradiotherapy using two-step method IMRT.
Twenty-six patients had mCBCT taken and were available for analysis.

Adverse events

There is nothing to report.

Outcome measures

The percent change in target and risk organ volumes and dose at week 1 as a reference (100%) was assessed by a paired T-test.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 12 Month 16 Day

Date of IRB

2017 Year 11 Month 22 Day

Anticipated trial start date

2018 Year 01 Month 01 Day

Last follow-up date

2019 Year 07 Month 01 Day

Date of closure to data entry

2020 Year 01 Month 31 Day

Date trial data considered complete

2020 Year 01 Month 31 Day

Date analysis concluded

2020 Year 01 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 10 Month 26 Day

Last modified on

2022 Year 04 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033965


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name